Pilot project funding for biomedical commercialization, LOIs due Nov. 1

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for Biomedical Innovation Program funding. The purpose of this funding opportunity is to accelerate the delivery of healthcare technologies from academia to the marketplace, thereby improving health care. This funding mechanism is offered in close collaboration with the School of Medicine Research Roadmap but is open to all OHSU faculty. All applicants are strongly encouraged to take advantage of the Innovation Drop In Session being held October 5, 2012 from 1 to 3 p.m. in the Hatfield Research Center, room 10D03.

Deadline: Letters of intent due November 1, 2012
Amount: Up to $40,000 over one year
Eligibility: Principal investigators must fit OHSU eligibility requirements.

Critical elements of successful proposals will be a well-developed idea or vision for the end product and collaboration between clinician scientists and bioengineers. The collaboration will help identify of a significant clinical problem, an innovative idea for a device to address the problem, bioengineering approaches for device development, and early clinical validation of device effectiveness.

Learn more about this and other OCTRI funding opportunities.